Investorideas.com newswire, breaking stock news, business news and commentary for marijuana sector

Monday, May 22, 2017

Global #Cannabis Testing Market Opportunity & Analysis, Featuring Thermo Fisher Scientific, Sigma-Aldrich, Agilent Technologies, Perkinelemer, Steep Hill Halent Laboratories & Eli Lilly

Global #Cannabis Testing Market Opportunity & Analysis, Featuring Thermo Fisher Scientific, Sigma-Aldrich, Agilent Technologies, Perkinelemer, Steep Hill Halent Laboratories & Eli Lilly


DUBLIN - May 22, 2017 (Investorideas.com Newswire) Research and Markets has announced the addition of the "Global Cannabis Testing Market Insights, Opportunity, Analysis, Market Shares And Forecast 2017 - 2023" report to their offering.
The global cannabis testing market is expected to grow with the CAGR of approximately 11.7% during the forecast period 2016-2023
Increasing demand for LIMS systems in cannabis testing is one of the major driving factors for the market.


Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp
Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.